Please assess the completion status of the following clinical trial:

Trial Title: Pharmacokinetics of Bolus Versus Continuous Cefazolin Infusion in Patients Undergoing Major Surgery

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age \> 18 years~* Elective abdominal and orthopedic surgery~* A patent arterial line~* A patent IV line~* Must be able to read and speak English~Exclusion Criteria:~* Subjects unable to give informed consent.~* Allergy to cefazolin~* Cognitively Impared~* Prisoners~* Pregnant females (self reported)~* History of coagulopathy~* Subjects presenting for emergency abdominal surgery~* Creatinine clearance \< 30 ml/min~* Received cefazolin within 72 hours prior to surgery

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- BOLUS INFUSION (Type: ACTIVE_COMPARATOR): Bolus infusion of antibiotics
- CONTINUOUS INFUSION (Type: EXPERIMENTAL): Continuous infusion of antibiotics by way of infusion pump

Based on this trial design, predict the completion outcome and termination type (if applicable).